home / stock / ebs / ebs news


EBS News and Press, Emergent Biosolutions Inc. From 08/22/23

Stock Information

Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com

Menu

EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...

EBS - SOS, ASO and MESO among pre-market losers

2023-08-22 08:18:03 ET Tingo Group ( TIO ) -29% postpones Q2 results yet again after Hindenburg short report . Dragonfly Energy Holdings Corp. ( DFLI ) -20% after Q2 earning release . DICK'S Sporting Goods ( DKS ) -19% after Q2 earning release ....

EBS - Kenvue to join S&P 500, replacing Advance Auto Parts

2023-08-21 18:12:53 ET More on Kenvue Kenvue rises on exchange offer oversubscription; JNJ falls Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You Kenvue: A Buffett-Style Investment At A Reasonable Price Johnson & Jo...

EBS - Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600

Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 PR Newswire NEW YORK , Aug. 21, 2023 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) will replace Advance ...

EBS - Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)

2023-08-14 01:23:21 ET Summary Emergent BioSolutions addresses public health threats; recent layoffs and operational cutbacks aim to save over $100 million annually. Despite Q2 2023 revenue increase, Emergent faces alarming cash burn, significant debt, and a predicted negative 3-y...

EBS - Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript

2023-08-09 00:30:51 ET Image source: The Motley Fool. Emergent BioSolutions (NYSE: EBS) Q2 2023 Earnings Call Aug 08, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Emergent BioSolutions (EBS) Q2 2023 Earnings Call...

EBS - Emergent BioSolutions, Inc. (EBS) Q2 2023 Earnings Call Transcript

2023-08-08 22:39:09 ET Emergent BioSolutions, Inc. (EBS) Q2 2023 Earnings Conference Call August 08, 2023, 17:00 ET Company Participants Matt Hartwig - IR Haywood Miller - Interim CEO Richard Lindahl - EVP, CFO & Treasurer Paul Williams - SVP, Products Bu...

EBS - Emergent Biosolutions Non-GAAP EPS of -$1.06 misses by $0.43, revenue of $337.9M beats by $121.15M

2023-08-08 16:37:49 ET Emergent Biosolutions press release ( NYSE: EBS ): Q2 Non-GAAP EPS of -$1.06 misses by $0.43 . Revenue of $337.9M (+39.2% Y/Y) beats by $121.15M . Guidance FY: Total Revenues $1,000M - $1,100M vs $1.16B consensus; Adj. net loss $(195M) - ...

EBS - Emergent BioSolutions Reports Financial Results for Second Quarter 2023

Reports Q2 2023 total revenues of $338M, above the prior guidance range, net loss of $261M and adjusted EBITDA of $56M Updates FY 2023 guidance and provides initial Q3 2023 forecast for total revenues GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:...

EBS - Emergent BioSolutions to cut 400 jobs, streamline operations

2023-08-08 08:05:12 ET Emergent BioSolutions ( NYSE: EBS ) Tuesday said it was reducing investment in its CDMO services business, and would lay off of about 400 employees across all areas of the company. As a result, Emergent would also cut operations at its Bayview facility i...

EBS - Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position

Actions bring sharpened focus on MCM and NARCAN ® Nasal Spray products Expected to improve operational efficiencies and deliver annual cost savings over $100 million annually GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced ...

Previous 10 Next 10